Wave Life Sciences: setback for Huntington’s disease trials
30. March 2021. Yesterday, Wave Life Sciences gave an update on PRECISION-HD1 and PRECISION-HD2. Due to disappointing results, the biotechnology company has decided to stop the two Huntington’s disease trials. […]
DNA Repair: Hot Topic in Huntington’s Research
DNA damage repair has become a hot topic in Huntington’s research. By targeting proteins involved in the repair process we might be able to slow down, or even prevent, Huntington’s […]
LIRH Conference: Current Treatment Perspectives for Huntington Disease
The Italian League for Research on Huntington Disease (LIRH) hosted their annual conference in December 2020. Watch a recording of their online meeting below (in English) and get an introduction to […]
Simple, Brief Summary of Ongoing Drug Development
A number of researchers are using a wide range of approaches to develop new treatments for Huntington’s disease. Here is a short summary of 2020 and what to expect in […]
WEBINAR | Summary of the year and looking ahead
Join our last webinar in 2020! Together with Prof. Anne Rosser, Dr. Ralf Reilmann and Dr. Alzbeta Mühlbäck we will take a look at recent achievements in drug development and make […]
PTC Therapeutics has started in-human Huntington’s disease trial
Two days ago, PTC Therapeutics announced that the drug candidate PTC518 has entered into a “Phase 1 Clinical Trial”. The initial results are expected in the first half of 2021. […]
Huntington’s Disease Podcast
The HD Insights Podcast by the Huntington Study Group is an interview series with the people working in Huntington’s disease research and treatments. The Huntington Study Group is a non-profit […]
Autumn News from the European Huntington Association
Join webinars, get updated on the latest research and learn more about our new project Moving Forward! Read our Autumn Newsletter! Click here.
The DOMINO-HD study: What is it and why are we doing it?
DOMINO-HD is a European study funded by the EU Joint Programme for Neurodegenerative Disease. The aim of the study is to investigate the relationship between genetic and lifestyle factors and […]
Moving Forward: Towards a Future with Effective Treatment for Huntington’s Disease
We are launching “Moving Forward”. The new project aims at including people from Huntington’s disease families in drug development by facilitating an active and long-lasting commitment from patients and family members. […]